Occupational Therapy for Parkinsonian Patients: A Retrospective Study

Table 1

Patients’ demographical, clinical, and neuropsychological data.

Variable	All	H&Y < 3	H&Y ≥ 3
Age (years)	67.1 ± 9.4	64.3 ± 10.2	70.3 ± 7.3	<0.0001
Male gender (%)	54.4	50.9	57.1	0.17
Right side (%)	55.3	47.8	61.6	0.004
Right-handed (%)	97.1	98.6	95.8	0.065
LED (mg)	618 ± 319	538 ± 294	711 ± 324	<0.0001
Disease duration (years)	8.9 ± 5.2	7.7 ± 5.0	10.2 ± 5.2	0.0002
H&Y	2.6 ± 0.5	2.2 ± 0.3	3.1 ± 0.3	<0.0001
Years of education	10.5 ± 4.4	11.0 ± 4.2	9.9 ± 4.6	0.002
FAB	13.9 ± 3.0	14.4 ± 2.8	13.2 ± 3.1	<0.0001
PDQ39	41.1 ± 22.1	34.8 ± 17.4	51.6 ± 24.9	<0.0001

LED: daily levodopa equivalent dose; H&Y: Hoehn and Yahr stage; FAB: frontal assessment battery; PDQ39: Parkinson disease’s Questionnaire 39.